Misonix Named Exclusive Domestic Distributor of Anika’s Hyalomatrix® Skin Substitute
Press Release Source: Anika Therapeutics On Wednesday June 1, 2011, 4:15 pm EDT
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq:ANIK - News), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (“HA”) technology, today announced Anika Therapeutics S.r.l., its wholly owned subsidiary, has entered into a new, five-year exclusive U.S. distribution agreement with Misonix, Inc. (Nasdaq:MSON - News), which will distribute and sell Anika’s Hyalomatrix®—an FDA-approved, HA-based skin substitute. One of the numerous products added to the Anika portfolio through its acquisition of Fidia Advanced Biopolymers (now Anika Therapeutics S.r.l.), Hyalomatrix is indicated for treatment of a wide range of acute and chronic wounds.
Anika will manufacture and supply finished product to Misonix, which will be responsible for all aspects of commercialization in the United States. A recognized leader in ultrasonic wound debridement, Misonix has dedicated U.S. sales and marketing organizations in both the clinical and surgical settings where acute and chronic wounds are treated.
“This is a promising new collaboration for Anika,” said Charles H. Sherwood, Ph.D., president and chief executive officer. “Misonix will be adding Hyalomatrix to its own proprietary technologies to create a comprehensive and leading-edge protocol for wound management. Given the knowledge of U.S. sales channels for wound care products that Misonix has acquired over the years, this agreement is an important milestone in Anika’s entry into the large and growing U.S. market for advanced wound treatment.”
Recent ANIK News
- Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 • GlobeNewswire Inc. • 04/18/2024 08:01:45 PM
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 12:00:28 PM
- Anika Reports Fourth Quarter and Year-End 2023 Financial Results • GlobeNewswire Inc. • 03/13/2024 08:05:34 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/08/2024 09:01:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 12:30:09 AM
- Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 02/27/2024 09:01:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 02:00:21 PM
- Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting • GlobeNewswire Inc. • 02/13/2024 02:00:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 04:09:33 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 07:27:19 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 01/22/2024 02:29:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/19/2024 09:52:43 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 01/12/2024 09:35:28 PM
- Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release • GlobeNewswire Inc. • 11/28/2023 02:00:43 PM
- Anika to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/07/2023 09:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:11:11 PM
- Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business • GlobeNewswire Inc. • 11/02/2023 08:05:12 PM
- Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023 • GlobeNewswire Inc. • 10/10/2023 01:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:31:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 11:55:16 AM
- Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting • GlobeNewswire Inc. • 09/19/2023 01:00:55 PM
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/15/2023 08:01:08 PM
- Anika to Participate in the Sidoti Small Cap Virtual Investor Conference • GlobeNewswire Inc. • 09/12/2023 01:00:38 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/11/2023 10:01:04 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM